TransMedics Group, Inc. (NASDAQ:TMDX) Given Average Rating of Moderate Buy by Brokerages

TransMedics Group, Inc. (NASDAQ:TMDX – Get Free Report) has been given a consensus rating of “Moderate Buy” by the eight analysts that are currently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1 year […]

Related Keywords

United States ,Waleedh Hassanein , ,Institutional Trading Of Transmedics Group ,Morgan Stanley ,Jpmorgan Chase Co ,Hightower Advisors ,Transmedics Group Company Profile ,Metlife Investment Management ,Transmedics Group Inc ,Transmedics Group Stock Performance ,Analyst Recommendations For Transmedics Group ,Transmedics Group ,Advisor Group Holdings Inc ,Nasdaq ,News Ratings For Transmedics Group Daily ,Get Free Report ,Group Holdings ,Tower Advisors ,Life Investment Management ,Rhumbline Advisers ,Medics Group ,Get Free ,Organ Care System ,Transmedics Group Daily ,Nasdaq Tmdx ,Tmdx ,Medical ,Ratings ,Consensus ,